Concepedia

Dona Alberti

DA

Statistics

Publications

58

Citations

3.3K

H-Index

31

Active since

1987

Affiliations

University of Wisconsin Carbone Cancer Center(Current)

University of Wisconsin–Madison

Spanish Oncology Genitourinary Group

University of Wisconsin System

National Cancer Institute

Dona Alberti is an author at University of Wisconsin Carbone Cancer Center specializing in pharmacology, medicine, and oncology.

Publications per year

1987–2013

58

Publications

58

Safety and Immunological Efficacy of a DNA Vaccine Encoding Prostatic Acid Phosphatase in Patients With Stage D0 Prostate Cancer

Douglas G. McNeel, Edward J. Dunphy, James G. Davies et al. · Journal of Clinical Oncology · 2009 · 250 citations · Full text

, , +17

Phase I Pharmacokinetic and Pharmacodynamic Study of Recombinant Human Endostatin in Patients With Advanced Solid Tumors

James P. Thomas, Rhoda Arzoomanian, Dona Alberti et al. · Journal of Clinical Oncology · 2003 · 226 citations

, , +16

Phase I clinical trial of intravenous L-buthionine sulfoximine and melphalan: an attempt at modulation of glutathione.

Howard H. Bailey, Ríona Mulcahy, K D Tutsch et al. · Journal of Clinical Oncology · 1994 · 186 citations

, , +11

Phase I Study of Continuous-Infusion L-S,R-Buthionine Sulfoximine With Intravenous Melphalan

Howard H. Bailey, Gregory H. Ripple, K D Tutsch et al. · JNCI Journal of the National Cancer Institute · 1997 · 165 citations · Full text

, , +15

Phase I Trial of a Monoclonal Antibody Specific for αvβ3 Integrin (MEDI-522) in Patients with Advanced Malignancies, Including an Assessment of Effect on Tumor Perfusion

Douglas G. McNeel, Jens C. Eickhoff, Fred T. Lee et al. · Clinical Cancer Research · 2005 · 158 citations

, , +17

1–5 of 58